Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073255
Status:
COMPLETED
Last Update Posted:
2010-01-15
First Post:
2003-11-18
Brief Title:
Safety and Pharmacokinetics PK of hOKT3g1 Ala-Ala in Type 1 Diabetes Mellitus T1DM
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Organization:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Study Overview
Official Title:
Evaluation of Tolerability Safety and Pharmacokinetics of hOKT3g1 Ala-Ala
Status:
COMPLETED
Status Verified Date:
2010-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the tolerability and safety of hOKT3g1 Ala-Ala after a 12-day dosing regimen administered via intravenous infusion To assess the pharmacokinetics of hOKT3g1 Ala-Ala
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None